These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21208837)

  • 21. Effects of weight reduction regimens and bariatric surgery on chronic kidney disease in obese patients.
    Abou-Mrad RM; Abu-Alfa AK; Ziyadeh FN
    Am J Physiol Renal Physiol; 2013 Sep; 305(5):F613-7. PubMed ID: 23825072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity, type 2 diabetes and risk of digestive cancer.
    Hillon P; Guiu B; Vincent J; Petit JM
    Gastroenterol Clin Biol; 2010 Oct; 34(10):529-33. PubMed ID: 20864282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between chronic kidney disease and silent cerebral infarction in patients with Type 2 diabetes.
    Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
    Diabet Med; 2010 May; 27(5):538-43. PubMed ID: 20536949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.
    Navarro-Díaz M; Serra A; Romero R; Bonet J; Bayés B; Homs M; Pérez N; Bonal J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S213-7. PubMed ID: 17130264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS).
    Jia W; Gao X; Pang C; Hou X; Bao Y; Liu W; Wang W; Zuo Y; Gu H; Xiang K
    Nephrol Dial Transplant; 2009 Dec; 24(12):3724-31. PubMed ID: 19617258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity and chronic kidney disease.
    Eknoyan G
    Nefrologia; 2011; 31(4):397-403. PubMed ID: 21623393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bariatric surgery for morbid obesity: risks and benefits in chronic kidney disease patients.
    Zalesin KC; McCullough PA
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):403-17. PubMed ID: 17045226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of chronic kidney disease in the Black Sea Region, Turkey, and investigation of the related factors with chronic kidney disease.
    Sahin I; Yildirim B; Cetin I; Etikan I; Ozturk B; Ozyurt H; Tasliyurt T
    Ren Fail; 2009; 31(10):920-7. PubMed ID: 20030527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
    Pisoni R; Faraone R; Ruggenent P; Remuzzi G
    J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy.
    Tsuboi N; Utsunomiya Y; Kanzaki G; Koike K; Ikegami M; Kawamura T; Hosoya T
    Clin J Am Soc Nephrol; 2012 May; 7(5):735-41. PubMed ID: 22403274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity, diabetes, adiponectin and the kidney: a podocyte affair.
    Zoccali C; Mallamaci F
    Nephrol Dial Transplant; 2008 Dec; 23(12):3767-70. PubMed ID: 18802210
    [No Abstract]   [Full Text] [Related]  

  • 34. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.
    Guebre-Egziabher F; Bernhard J; Funahashi T; Hadj-Aissa A; Fouque D
    Nephrol Dial Transplant; 2005 Jan; 20(1):129-34. PubMed ID: 15585515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the glomerular filtration rate in obese adult patients for drug dosing.
    Pai MP
    Adv Chronic Kidney Dis; 2010 Sep; 17(5):e53-62. PubMed ID: 20727504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic kidney disease what is it?].
    Joly D
    Rev Prat; 2012 Jan; 62(1):34-7. PubMed ID: 22335064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and risk factors for CKD in spouses and relatives of hemodialysis patients.
    Tsai JC; Chen SC; Hwang SJ; Chang JM; Lin MY; Chen HC
    Am J Kidney Dis; 2010 May; 55(5):856-66. PubMed ID: 20153917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
    See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
    J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of acute functional injury following percutaneous renal artery intervention.
    Davies MG; Saad WE; Peden EK; Mohiuddin IT; Naoum JJ; Lumsden AB
    Ann Vasc Surg; 2008 Nov; 22(6):783-9. PubMed ID: 18692990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of obesity and chronic kidney disease.
    Ross WR; McGill JB
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):325-35. PubMed ID: 17045219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.